Y. Hara, “Clinical Utility of Targeted Next-Generation Sequencing for Determining Human Epidermal Growth Factor Receptor 2 Status and Optimizing Targeted Therapy in Breast Cancer”, World J Oncol, Jul. 2025, doi: 10.14740/wjon2583.